Net Income
Net Income
Kailera Therapeutics Net Income decreased by 338.6% to -$78.87M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionNet Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
Detailed definition
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
Peer comparison
The most common metric for evaluating company performance against industry competitors.
Metric ID:
net_incomeHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | -$17.98M | -$78.87M |
| QoQ Change | — | -338.6% |
| YoY Change | — | -338.6% |
Range-$78.87M – -$17.98M
Avg YoY Growth-338.6%
Median YoY Growth-338.6%
Net Income at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's net income?
- Kailera Therapeutics (KLRA) reported net income of -$78.87M in Q1 2026.
- What does net income mean?
- The total profit remaining after all costs, expenses, and taxes have been paid.